Cellectis (CLLS) Current Leases (2016 - 2026)
Cellectis (CLLS) recorded quarterly Current Leases of $6.3 million in Q1 2026, down 18.78% quarter-over-quarter from $7.7 million in Q4 2025, and down 20.44% on a YoY basis from $7.9 million in Q1 2025.
Cellectis (CLLS) Current Leases (2016 - 2026) Analysis & Trends
Cellectis' Current Leases history runs 11 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- In Q1 2026, Current Leases fell 20.44% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 20.44% YoY), while the FY2025 annual figure was $7.7 million, down 8.16% from the prior year.
- Current Leases was $6.3 million for Q1 2026 at Cellectis, down from $7.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $8.5 million in Q3 2024 to a low of $6.3 million in Q1 2026.
- Historically, Current Leases has averaged $8.0 million across 5 years, with a median of $8.2 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Current Leases climbed 20.37% in 2022, then declined 20.44% in 2026.
- A 5-year view of Current Leases shows it stood at $7.9 million in 2022, then increased by 8.0% to $8.5 million in 2023, then declined by 1.38% to $8.4 million in 2024, then dropped by 8.16% to $7.7 million in 2025, then retreated by 18.78% to $6.3 million in 2026.
- The last three Current Leases figures came in at $6.3 million (Q1 2026), $7.7 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | 6.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.26 Mn |
| Dec 31, 2025 | 7.70 Mn |
| Sep 30, 2025 | 8.33 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 8.39 Mn |
| Sep 30, 2024 | 8.51 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Sep 30, 2023 | 8.20 Mn |
| Jun 30, 2023 | 8.27 Mn |
| Mar 31, 2023 | 8.18 Mn |
| Dec 31, 2022 | 7.87 Mn |
| Sep 30, 2022 | 7.97 Mn |
| Jun 30, 2022 | 8.09 Mn |
| Mar 31, 2022 | 8.41 Mn |
| Dec 31, 2021 | 8.33 Mn |
| Sep 30, 2021 | 8.08 Mn |
| Jun 30, 2021 | 7.69 Mn |